Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-03-20
DOI
10.3389/fphar.2018.00249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonsurgical lumbar radiculopathies treated with ultramicronized palmitoylethanolamide (umPEA): A series of 100 cases
- (2018) Domenico Chirchiglia et al. Neurologia i Neurochirurgia Polska
- Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
- (2018) Caterina Scuderi et al. Translational Psychiatry
- Neuro-immune interactions in allergic diseases: novel targets for therapeutics
- (2017) Tiphaine Voisin et al. INTERNATIONAL IMMUNOLOGY
- Palmitoylethanolamide sub-micronization using fast precipitation followed by supercritical fluids extraction
- (2017) R. Campardelli et al. POWDER TECHNOLOGY
- Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture model
- (2017) Francesca Abramo et al. VETERINARY DERMATOLOGY
- The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
- (2017) Maria Beatrice Passavanti et al. BMC Anesthesiology
- 2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation
- (2017) Stefania Petrosino et al. Frontiers in Pharmacology
- Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia
- (2017) Rosalba Siracusa et al. Frontiers in Neurology
- Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
- (2016) Linda Gabrielsson et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
- (2016) Stefania Petrosino et al. BRITISH JOURNAL OF PHARMACOLOGY
- A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation
- (2016) E. Esposito et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- KU0063794, a Dual mTORC1 and mTORC2 Inhibitor, Reduces Neural Tissue Damage and Locomotor Impairment After Spinal Cord Injury in Mice
- (2016) Marika Cordaro et al. MOLECULAR NEUROBIOLOGY
- Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis
- (2016) Teresa Iuvone et al. PAIN
- 2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation
- (2016) Daniela Impellizzeri et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
- (2016) Fabio Arturo Iannotti et al. PROGRESS IN LIPID RESEARCH
- Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential
- (2016) Earle R. Nestmann Food Science & Nutrition
- The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels
- (2015) Stefania Petrosino et al. BRITISH JOURNAL OF PHARMACOLOGY
- Palmitoylethanolamide Relieves Pain and Preserves Pancreatic Islet Cells in a Murine Model of Diabetes
- (2015) Giulia Donvito et al. CNS & Neurological Disorders-Drug Targets
- Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study
- (2015) Chiara Noli et al. VETERINARY DERMATOLOGY
- Delay of Morphine Tolerance by Palmitoylethanolamide
- (2015) Lorenzo Di Cesare Mannelli et al. Biomed Research International
- Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats
- (2015) Federica Vacondio et al. PLoS One
- Synthesis and Preliminary Evaluation of N-(16-18F-Fluorohexadecanoyl)ethanolamine (18F-FHEA) as a PET Probe of N-Acylethanolamine Metabolism in Mouse Brain
- (2014) Mukesh K. Pandey et al. ACS Chemical Neuroscience
- Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis
- (2014) Francesca Abramo et al. BMC Veterinary Research
- Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
- (2014) Daniela Impellizzeri et al. Journal of Neuroinflammation
- Peripheral gating of pain signals by endogenous lipid mediators
- (2014) Daniele Piomelli et al. NATURE NEUROSCIENCE
- Down-regulation of PPARα in the spinal cord contributes to augmented peripheral inflammation and inflammatory hyperalgesia in diet-induced obese rats
- (2014) J. Wang et al. NEUROSCIENCE
- A control strategy for bioavailability enhancement by size reduction: Effect of micronization conditions on the bulk, surface and blending characteristics of an active pharmaceutical ingredient
- (2014) Dolapo Olusanmi et al. POWDER TECHNOLOGY
- New Insights in Mast Cell Modulation by Palmitoylethanolamide
- (2013) D. De Filippis et al. CNS & Neurological Disorders-Drug Targets
- Recent advancements in mechanical reduction methods: particulate systems
- (2013) Jardin Leleux et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma
- (2013) Emanuela Esposito et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
- (2013) Stephen D. Skaper et al. MOLECULAR NEUROBIOLOGY
- Perineural Mast Cells Are Specifically Enriched in Pancreatic Neuritis and Neuropathic Pain in Pancreatic Cancer and Chronic Pancreatitis
- (2013) Ihsan Ekin Demir et al. PLoS One
- N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids
- (2013) Peter Koulen et al. Drug Design Development and Therapy
- Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain
- (2013) Stephen D. Skaper et al. INFLAMMOPHARMACOLOGY
- Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice
- (2012) Akbar Ahmad et al. BRAIN BEHAVIOR AND IMMUNITY
- Palmitoylethanolamide Restores Myelinated-Fibre Function in Patients with Chemotherapy-Induced Painful Neuropathy
- (2012) A. Truini et al. CNS & Neurological Disorders-Drug Targets
- Effects of Peripheral Inflammation on the Blood-Spinal Cord Barrier
- (2012) Dimitris N Xanthos et al. Molecular Pain
- Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
- (2012) Giuseppe D'Agostino et al. NEUROPSYCHOPHARMACOLOGY
- Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis
- (2012) Antonio Gatti et al. PAIN MEDICINE
- Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
- (2012) S. D. Skaper et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells
- (2011) Giuseppina Cantarella et al. BIOCHEMICAL PHARMACOLOGY
- Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury
- (2011) Emanuela Esposito et al. BRAIN BEHAVIOR AND IMMUNITY
- Palmitoylethanolamide Reduces Granuloma-Induced Hyperalgesia by Modulation of Mast Cell Activation in Rats
- (2011) Daniele De Filippis et al. Molecular Pain
- LC–MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies
- (2011) Kuldeep Sharma et al. Bioanalysis
- Effects of Hypericum Perforatum, in a rodent model of periodontitis
- (2010) Irene Paterniti et al. BMC Complementary and Alternative Medicine
- Protective role of palmitoylethanolamide in contact allergic dermatitis
- (2009) S. Petrosino et al. ALLERGY
- Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells
- (2009) Zun-Yi Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia
- (2009) Giuseppe D'Agostino et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CNS penetration of small molecules following local inflammation, widespread systemic inflammation or direct injury to the nervous system
- (2009) Peimin Lu et al. LIFE SCIENCES
- Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation
- (2009) C. Solorzano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cells
- (2009) S. Cerrato et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models
- (2009) Jun Soo Bang et al. ARTHRITIS RESEARCH & THERAPY
- ‘Entourage’ effects ofN-palmitoylethanolamide andN-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
- (2008) W-SV Ho et al. BRITISH JOURNAL OF PHARMACOLOGY
- Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide
- (2008) Frida Loría et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Increased mast cell numbers in the conjunctiva of glaucoma patients: a possible indicator of preoperative glaucoma surgery inflammation
- (2008) L Chang et al. EYE
- Effects of Palmitoylethanolamide on Signaling Pathways Implicated in the Development of Spinal Cord Injury
- (2008) T. Genovese et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The endocannabinoid system is modulated in response to spinal cord injury in rats
- (2008) Daniel Garcia-Ovejero et al. NEUROBIOLOGY OF DISEASE
- The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARγ receptors and neurotrophic factors
- (2008) Barbara Costa et al. PAIN
- Rate-Limiting Steps of Oral Absorption for Poorly Water-Soluble Drugs in Dogs; Prediction from a Miniscale Dissolution Test and a Physiologically-Based Computer Simulation
- (2008) Ryusuke Takano et al. PHARMACEUTICAL RESEARCH
- Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease
- (2007) Tiziana Bisogno et al. NEUROCHEMISTRY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now